| Financial Year |
March 31 2023 |
| Monetary Funds |
124,291,076.41 |
| Held-for-trading Financial Assets |
41,000,000.00 |
| Notes Receivable |
463,500.00 |
| Accounts Receivable |
546,565,371.54 |
| Advances to Suppliers |
18,411,293.81 |
| Other Receivables |
19,893,224.09 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
56,532,603.63 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
36,473,008.80 |
| Other Current Assets |
3,110,021.22 |
| Total Current Assets |
847,952,356.95 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
24,621,512.98 |
| Long-term Equity Investment |
-- |
| Investment Properties |
122,950,918.58 |
| Fixed Assetes |
312,257,323.11 |
| Under-construction Projects |
5,449,527.86 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
37,959,286.10 |
| R&D expenses |
-- |
| Goodwill |
104,703,534.05 |
| Long-Term Deferred and Prepaid Expenses |
7,027,852.98 |
| Deferred Income Tax Assets |
57,388,984.66 |
| Other Non-Current Assets |
28,015,926.74 |
| Sub-Total of Non-Current Assets |
716,247,458.74 |
| Total Assets |
1,564,199,815.69 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
145,283,664.48 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
3,108,475.21 |
| Taxes Payable |
5,034,256.05 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
13,722,658.91 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
9,556,858.33 |
| Other Current Liabilities |
80,066,125.39 |
| Sub-Total of Current Liabilities |
294,556,090.29 |
| Long-term Loans |
132,500,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
17,721,810.00 |
| Deferred Income Tax Liabilities |
21,925,882.13 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
178,339,111.02 |
| Total Liabilities |
472,895,201.31 |
| Paid-In Capital(Or Share Stock) |
531,020,900.00 |
| Capital Surplus |
197,897,852.80 |
| Surplus Reserve |
64,635,515.53 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
277,129,183.36 |
| Minority Stockholder's Interest |
51,561,162.69 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,039,743,451.69 |
| Owner's Equity（Stockholder's Equity） |
1,091,304,614.38 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,564,199,815.69 |
